58 related articles for article (PubMed ID: 501087)
1. Generation of biologic activity from the purified alpha-chain of C5.
Phan SH; Ward PA
J Immunol; 1979 Dec; 123(6):2735-40. PubMed ID: 501087
[TBL] [Abstract][Full Text] [Related]
2. Fifth component of guinea pig complement: purification and characterization.
Kinoshita T; Hong K; Kondo K; Inoue K
J Immunol; 1981 Jun; 126(6):2414-8. PubMed ID: 7229382
[TBL] [Abstract][Full Text] [Related]
3. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
Hammer CH; Hänsch G; Gresham HD; Shin ML
J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934
[TBL] [Abstract][Full Text] [Related]
4. Expression of C5a-like biological activities by the fifth component of human complement (C5) upon limited digestion with noncomplement enzymes without release of polypeptide fragments.
Wetsel RA; Kolb WP
J Exp Med; 1983 Jun; 157(6):2029-48. PubMed ID: 6222137
[TBL] [Abstract][Full Text] [Related]
5. Purification of the fourth, second and fifth components of mouse complement.
Fukuoka Y; Seino J; Okuda T; Tachibana T
Immunology; 1984 Mar; 51(3):493-501. PubMed ID: 6698577
[TBL] [Abstract][Full Text] [Related]
6. Cleavage of human C5 by trypsin: characterization of the digestion products by gel electrophoresis.
Minta JO; Man DP
J Immunol; 1977 Nov; 119(5):1597-1602. PubMed ID: 410877
[TBL] [Abstract][Full Text] [Related]
7. Structural features and biologic properties of fragments obtained by limited proteolysis of C3.
Conroy MC; Ozols J; Lepow IH
J Immunol; 1976 Jun; 116(6):1682-7. PubMed ID: 774990
[TBL] [Abstract][Full Text] [Related]
8. Digestion of the fifth component of complement by leukocyte enzymes. Sequential generation of chemotactic activities for leukocytes and for tumor cells.
Orr FW; Varani J; Kreutzer DL; Senior RM; Ward PA
Am J Pathol; 1979 Jan; 94(1):75-83. PubMed ID: 569981
[TBL] [Abstract][Full Text] [Related]
9. Limited proteolysis of C5b-6: functional stability of the degraded complex.
Podack ER; Müller-Eberhard HJ
J Immunol; 1980 Jan; 124(1):332-6. PubMed ID: 6444229
[No Abstract] [Full Text] [Related]
10. Generation of biologically active, complement-(C5) derived peptides by cathepsin H.
Perez HD; Ohtani O; Banda D; Ong R; Fukuyama K; Goldstein IM
J Immunol; 1983 Jul; 131(1):397-402. PubMed ID: 6408181
[TBL] [Abstract][Full Text] [Related]
11. Demonstration of C5 cleaving activity in bronchoalveolar fluids and cells: a mechanism of acute and chronic alveolitis.
Desai U; Dickey B; Varani J; Kreutzer DL
J Exp Pathol; 1984; 1(3):201-16. PubMed ID: 6400640
[TBL] [Abstract][Full Text] [Related]
12. Human C3 and C5: subunit structure and modifications by trypsin and C42-C423.
Nilsson UR; Mandle RJ; McConnell-Mapes JA
J Immunol; 1975 Feb; 114(2 pt 2):815-22. PubMed ID: 1112981
[TBL] [Abstract][Full Text] [Related]
13. C5 chemotactic fragment induces leukocyte production of tissue factor activity: a link between complement and coagulation.
Muhlfelder TW; Niemetz J; Kreutzer D; Beebe D; Ward PA; Rosenfeld SI
J Clin Invest; 1979 Jan; 63(1):147-50. PubMed ID: 762243
[TBL] [Abstract][Full Text] [Related]
14. Chemotactic activity generated in human serum from the fifth component of complement by hydrogen peroxide.
Shingu M; Nobunaga M
Am J Pathol; 1984 Nov; 117(2):201-6. PubMed ID: 6388344
[TBL] [Abstract][Full Text] [Related]
15. Complement-independent activation of the fifth component (C5) of human complement: limited trypsin digestion resulting in the expression of biological activity.
Wetsel RA; Kolb WP
J Immunol; 1982 May; 128(5):2209-16. PubMed ID: 7061860
[No Abstract] [Full Text] [Related]
16. A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.
Perez HD; Lipton M; Goldstein IM
J Clin Invest; 1978 Jul; 62(1):29-38. PubMed ID: 659635
[TBL] [Abstract][Full Text] [Related]
17. Isolation of the fifth component of the bovine complement system.
Aston WP; Mhatre A; Macrae J
Vet Immunol Immunopathol; 1990 Apr; 24(4):301-12. PubMed ID: 2140216
[TBL] [Abstract][Full Text] [Related]
18. A single arginine to tryptophan interchange at beta-chain residue 458 of human complement component C4 accounts for the defect in classical pathway C5 convertase activity of allotype C4A6. Implications for the location of a C5 binding site in C4.
Ebanks RO; Jaikaran AS; Carroll MC; Anderson MJ; Campbell RD; Isenman DE
J Immunol; 1992 May; 148(9):2803-11. PubMed ID: 1573269
[TBL] [Abstract][Full Text] [Related]
19. Isolation, characterization and utilization of the fifth component (C5) of porcine complement.
Vĕtvicka V; Zídková J; Fornůsek L; Ríhová B
Folia Biol (Praha); 1986; 32(3):195-208. PubMed ID: 2943607
[TBL] [Abstract][Full Text] [Related]
20. Effect of reduction on the structural, biologic, and immunologic properties of the third component of human complement.
Zemel ES; Cartwright-Harwick CM; Nilsson UR
J Immunol; 1980 Sep; 125(3):1099-103. PubMed ID: 7410831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
